AVI KATZ LORAL SPACE & COMMUNICATIONS LTD. C/O LORAL SPACECOM CORPORATION 600 THIRD AVENUE NEW YORK, NY 10016 (212) 697-1105 (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICE AND COMMUNICATIONS ON BEHALF OF THE PERSON(S)...Tender Offer Statement • August 27th, 2002 • Loral Space & Communications LTD • Radio & tv broadcasting & communications equipment
SCHEDULE 13DTender Offer Statement • September 7th, 2019
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • September 8th, 2019
* Estimated solely for purposes of calculating the amount of filing fee. The amount assumes the purchase of 15,473,597 shares of Common Stock, par value
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-1Tender Offer Statement • January 7th, 2018
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • September 8th, 2019
* Estimated solely for purposes of calculating the amount of filing fee. The amount assumes the purchase of 19,121,827 shares of Class A Common Stock, par value $.01 per share of the Subject Company (the "Shares"), at a price per
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • September 8th, 2019
* Estimated solely for purposes of calculating the amount of filing fee. The amount assumes the purchase of 15,473,597 shares of Common Stock, par value
SECURITIES AND EXCHANGE COMMISSIONTender Offer Statement • June 13th, 2017
AGREEMENT AND PLAN OF MERGER, dated as of August 9, 1995 (this "Agreement"), among Humana Inc., a Delaware corporation ("Parent"), HEW, Inc., a Delaware corporation ("Sub") and a wholly owned subsidiary of Parent, and EMPHESYS Financial Group, Inc., a Delaware corporation (the "Company") (Sub and the Company being hereinafter collectively referred to as the "Constituent Corporations").
TOTender Offer Statement • August 8th, 2019
OMB APPROVALTender Offer Statement • May 8th, 2017
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • October 5th, 2017
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • June 26th, 2019
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • September 7th, 2019 • New York
* Estimated solely for purposes of calculating the amount of filing fee. The amount assumes the purchase of 15,473,597 shares of Common Stock, par value
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • October 5th, 2017
BT Securities and Chemical Securities as co-syndication agents and Credit Suisse, as Issuing Bank (as defined below) and documentation agent.
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • October 5th, 2017
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1Tender Offer Statement • September 16th, 2017
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549Tender Offer Statement • May 27th, 2019 • Delaware
* Calculated solely for purposes of determining the filing fee. This amount assumes that options to purchase 12,449,300 shares of common stock of Akamai Technologies, Inc. having an aggregate value of $32,051,776 as of April 3, 2001 will be exchanged pursuant to this offer. The aggregate value of such options was calculated based on the Black-Scholes option pricing model. The amount of the filing fee, calculated in accordance with Rule
OF THE SECURITIES EXCHANGE ACT OF 1934Tender Offer Statement • January 12th, 2018
CARL SPIELVOGEL........................... Mr. Spielvogel has been the Chairman and Chief Executive Director since 1992 Officer of Carl Spielvogel Associates, Inc.
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14D-1Tender Offer Statement • July 7th, 2019 • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of November 17, 1994, is among Amgen Inc., a Delaware corporation ("Parent"), Amgen Acquisition Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and Synergen, Inc., a Delaware corporation ("Company").
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549Tender Offer Statement • June 26th, 2019
ContractTender Offer Statement • May 5th, 2020
COMMON STOCK, PAR VALUE $1.00 PER SHARE (INCLUDING THE ASSOCIATED PREFERRED STOCK PURCHASE RIGHTS)Tender Offer Statement • December 27th, 2018
